Lyka Labs secures Indian patent for Pregabalin Gel 8% - Indian Pharma Post
2025-04-08 • Google News
Lyka Labs Limited (LYKALABS)
NSEINR 99.44-0.19%
Price Chart
Key Statistics
Market Cap
INR 3.55B
P/E Ratio
47.35
Revenue (TTM)
INR 1.38B
Volume
16.93K
52W High
INR 176.59
52W Low
INR 96.80
Dividend Yield
0.00%
Beta
0.61
Technicals
50-Day MA
107.0946
200-Day MA
122.2736
52 Week High
176.59
52 Week Low
96.8
About LYKALABS
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various .
Employees
499
Headquarters
Mumbai, India
CEO
Mr. Kunal Narendra Gandhi
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg